Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG)

Dirk-Jan van Beek, Sjoerd Nell, Carolina R. C. Pieterman, Wouter W. de Herder, Annenienke C. van de Ven, Olaf M. Dekkers, Anouk N. van der Horst-Schrivers, Madeleine L. Drent, Peter H. Bisschop, Bas Havekes, Inne H. M. Borel Rinkes, Menno R. Vriens, Gerlof D. Valk*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)966-975
Number of pages10
JournalJournal of Surgical Oncology
Volume120
Issue number6
Early online date10 Aug 2019
DOIs
Publication statusPublished - Nov 2019

Keywords

  • multiple endocrine neoplasia type 1
  • neuroendocrine tumor
  • oncology
  • Zollinger-Ellison syndrome
  • ENDOCRINE NEOPLASIA TYPE-1
  • ZOLLINGER-ELLISON-SYNDROME
  • PANCREATIC NEUROENDOCRINE TUMORS
  • NATURAL-HISTORY
  • GUIDELINES
  • MANAGEMENT
  • DIAGNOSIS
  • SURGERY

Cite this

van Beek, D-J., Nell, S., Pieterman, C. R. C., de Herder, W. W., van de Ven, A. C., Dekkers, O. M., van der Horst-Schrivers, A. N., Drent, M. L., Bisschop, P. H., Havekes, B., Rinkes, I. H. M. B., Vriens, M. R., & Valk, G. D. (2019). Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG). Journal of Surgical Oncology, 120(6), 966-975. https://doi.org/10.1002/jso.25667